Skip to main content
. 2017 Jul 5;8(34):57278–57301. doi: 10.18632/oncotarget.18985

Figure 4. Comparative results of principle component analysis (with two components) for Biomarkers I and II according to clinical diagnoses (pathological categories or GS).

Figure 4

The analysis was performed with cells located only in the E-compartment, which showed highest differential results in the first analysis (Figure 3).